The year in damages in the US

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The year in damages in the US

Compared to 2013, this year has seen fewer blockbuster damages awards, with none of more than $500 million. But courts still awarded more than $100 million in eight cases

The largest award came out of the District of Delaware, which ordered Philips to pay Masimo $467 million for infringing patents covering technology used in fingertip devices that measure blood oxygen and pulse rates.

This followed the same court in January awarding Edwards LifeScience $394 million for Medtronic CoreValve for infringing patents covering a heart-valve device. The two companies later agreed to settle all global patent litigation in May, with Edwards LifeSciences paying a $750 million one-time payment and ongoing royalty payments.

Carnegie Melon University, ViaSatr, Alfred E Mann Foundation, WesternGeco, Apple and Power Integrations were also awarded damages of more than $100 million in 2014.

This compares with 2013 when two awards of more than $500 million were given. DuPont was ordered to pay $1 billion of damages to Monsanto in a GMO seed case. And Samsung was ordered to pay Apple $599 million in one of two large awards that year.

Managing IP will be publishing an in-depth look at the year in damages in early January. 


Top damages awards 2014

Rank

Against

Beneficiary

Case

Court

Total damages

1

Philips Electronics North America

Masimo Corporation

Masimo Corporation v Philips Electronics North America Corporation

DED

$467m

2

Medtronic CoreValve

Edwards Lifesciences

Edwards Lifesciences v Medtronic Corevalve

DED

$394m

3

Marvell Technology Group

Carnegie Mellon University

Carnegie Mellon University v Marvell Technology Group

PAWD

$367m

4

Space Systems/Loral

ViaSat

Viasat v Space Systems/Loral

CASD

$283m

5

Cochlear Corporation

Alfred E Mann Foundation For Scientific Research

Alfred E Mann Foundation for Scientific Research v Cochlear Corporation

CACD

$131m

6

Samsung Electronics

Apple

Apple v Samsung Electronics

CAND

$120m

7

ION Geophysical Corporation

WesternGeco

WesternGeco v ION Geophysical Corporation

TXSD

$115m

8

Fairchild Semiconductor International

Power Integrations

Power Integrations v Fairchild Semiconductor International

CAND

$105m

9

Google

SimpleAir

SimpleAir v Google

TXED

$85m

10

Sorenson Communications

Ultratec

Ultratec v Sorenson Communications

WIWD

$44m

Source: Docket Navigator

more from across site and SHARED ros bottom lb

More from across our site

New awards, including US ‘Firm of the Year’ and Latin America ‘Firm to Watch’, are among more than 90 prizes that will recognise firms and practitioners
DWF helped client Dairy UK secure a major victory at the UK Supreme Court
Hepworth Browne led Emotional Perception AI to victory at the UK Supreme Court, which rejected a previous appellate decision that said an AI network was not patentable
James Hill, general counsel at Norwich City FC, reveals how he balances fan engagement with brand enforcement, and when he calls on IP firms for advice
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
News of Avanci Video signing its first video licence and a win for patent innovators in Australia were also among the top talking points
Tom Melsheimer, part of a nine-partner team to join King & Spalding from Winston & Strawn, says the move reflects Texas’s appeal as a venue for high-stakes patent litigation
AI patents and dairy trademarks are at the centre of two judgments to be handed down next week
Jennifer Che explains how taking on the managing director role at her firm has offered a new perspective, and why Hong Kong is seeing a life sciences boom
Gift this article